2025-04-16 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**0) Introduction:**  UnitedHealth Group Inc. (UNH) is a diversified healthcare company providing health benefits, services, and information products. This report analyzes UNH's recent performance, comparing it to the S&P 500 (VOO) and assessing its risk and potential returns.

**1) Performance vs. S&P 500:**

UNH's cumulative return is significantly higher than the S&P 500's.

* **UNH Cumulative Return:** 75.86%
* **VOO (S&P 500) Cumulative Return:** 66.27%
* **Return Difference:** 9.59%

The relative divergence of 53.2% indicates that UNH's performance has been considerably above the S&P 500 in the context of its historical performance range (-38.8% to 52.2%).

**Alpha and Beta Analysis:**

The provided data shows variable alpha and beta values over the years.  Alpha is generally positive, suggesting outperformance compared to the market benchmark, while the beta indicates varying levels of market sensitivity.  Note that a high MDD (Maximum Drawdown) is observed in some periods, signifying substantial potential risk. The significant increase in market capitalization (Cap(B)) reflects company growth.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 64.0% | 56.1% | 35.0% | 0.1 | 181.0 |
| 2016-2018  | 55.0% | 63.9% | 37.0% | 0.2 | 207.3 |
| 2017-2019  | 41.0% | 63.9% | 11.0% | 0.3 | 248.8 |
| 2018-2020  | -20.0% | 63.9% | -45.0% | 0.5 | 301.7 |
| 2019-2021  | 34.0% | 60.8% | -20.0% | 0.6 | 438.0 |
| 2020-2022  | 28.0% | 67.1% | 22.0% | 0.6 | 468.4 |
| 2021-2023  | 35.0% | 67.6% | 18.0% | 0.4 | 472.1 |
| 2022-2024  | -27.0% | 68.8% | -44.0% | 0.3 | 460.8 |
| 2023-2025  | -1.0% | 73.2% | -15.0% | 0.2 | 533.8 |


**2) Recent Price Movement:**

UNH's recent price action shows a slight downward trend.

* **Closing Price:** $583.59
* **5-Day Moving Average:** $588.60
* **20-Day Moving Average:** $538.38
* **60-Day Moving Average:** $516.56

The price is currently below its 5-day and 20-day moving averages, indicating short-term bearish pressure.  However, it is above the 60-day moving average, suggesting a potential longer-term uptrend.  The recent price change (-$0.59) is relatively small and doesn't signal a dramatic shift.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4175 (Medium Risk)
* **RSI:** 74.25 (Oversold territory, suggesting potential correction)
* **PPO:** 1.19 (Positive, indicating bullish momentum)
* **Recent Relative Divergence Change:** -4.1% (Short-term bearish trend)
* **Expected Return:** 12.0% (Long-term expected outperformance vs. S&P 500)

The high RSI suggests the stock might be overbought, increasing the potential for a price correction.  However, the positive PPO and expected return suggest a relatively positive outlook for long-term investors.

**4) Recent Earnings Analysis:**

The earnings data shows fluctuating EPS and relatively stable revenue.  Note the significant negative EPS in Q2 2024. Further investigation is required to understand the cause of this anomaly.

| 날짜       | EPS    | 매출           |
|------------|--------|-----------------|
| 2024-11-04 | 6.56   | 100.82 B$       |
| 2024-08-09 | 4.58   | 98.86 B$       |
| 2024-05-09 | -1.53  | 99.80 B$       |
| 2023-11-06 | 6.31   | 92.36 B$       |
| 2024-11-04 | 6.31   | 92.36 B$       |


**5) Financial Information:**

Revenue has remained relatively stable, with profit margins consistently high.  ROE (Return on Equity) shows variability, with a notable negative value in Q1 2024.  Further analysis is needed to understand the factors driving this fluctuation.

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |
| 2024-06-30 | $98.86B    | 22.31%        |
| 2024-03-31 | $99.80B    | 23.05%        |
| 2023-12-31 | $94.43B    | 23.30%        |

**Capital and Profitability:**

| Quarter | Equity      | ROE    |
|---------|-------------|--------|
| 2024-12-31 | $92.66B    | 5.98%  |
| 2024-09-30 | $94.53B    | 6.41%  |
| 2024-06-30 | $89.36B    | 4.72%  |
| 2024-03-31 | $86.69B    | -1.63% |
| 2023-12-31 | $88.76B    | 6.15%  |


**6) Overall Analysis:**

UNH has shown strong historical performance, consistently outperforming the S&P 500.  However, recent data reveals some inconsistencies, including a negative EPS in Q2 2024 and a fluctuating ROE. While the long-term outlook remains positive, supported by a high expected return, investors should be aware of the potential for short-term corrections indicated by the high RSI and recent price movements.  Further investigation into the causes of the negative EPS and ROE fluctuations is crucial before making any investment decisions.  The company's substantial market capitalization suggests a degree of resilience, but the historical MDD figures highlight the importance of risk management.
